A case with myasthenia gravis (MG) emerging after splenectomy for idiopathic thrombocytopenic purpura (ITP): Possible effects of thymectomy on autoantibodies
Source: Journal of Medicine
Correction to Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study (The Lancet Neurology (2023) 22(7) (578–590), (S1474442223001941), (10.1016/S1474-4422(23)00194-1))
Source: Lancet Neurology
The efficacy of eculizumab against post-thymectomy exacerbations in thymoma associated myasthenia gravis (MG)
Source: Clinical Neurology
Myasthenia gravis (MG) in adults from institutions pertaining to the Mexican public health system: An analysis of hospital discharges during 2010
Source: Gaceta Medica De Mexico
Human leukocyte antigens (HLA) association with myasthenia gravis (MG) and its myasthenia manifestations in Algerian patients
Source: Meta Gene
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2025 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
